Cancidas Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients
Condition:   Candida InfectionsIntervention:   Sponsors:   Outcome Rea;   Assistance Publique - Hôpitaux de ParisNot yet recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2015 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials